CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5105-5111

  Muta, H ^a   Boise, L H ^a   Fang, L ^a   Podack, E R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; GRANZYME B; PERFORIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE EXPRESSION REGULATION; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTE TRANSFER; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0034327179     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5105     Document Type: Article

References (35)

1. CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disorders
2. CD30 ligand (CD30L)-expressing acute myeloid leukemias: A new model of aracrine interactions for the regulation of blast cells proliferation
3. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines
4. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
5. CD30 in normal and neoplastic cells
6. In vitro cell death of activated lymphocytes in Omenn's syndrome
7. CD30: Expressionand function in health and disease
8. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis
9. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines
10. + T cells by IL-4 and IFN-γ
11. Structure and expression of murine CD30 and its role in cytokine production
12. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity
13. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
14. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
15. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins
16. Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5)
17. CD30/TNF receptor-associated factor interaction: NF-κB activationand binding specificity
18. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2
19. CD30-dependent degradation of TRAF2 implication for negative regulation of TRAF signaling and the control of cell survival
20. TRAF-interacting protein (TRIP): A novel compnent of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation
21. Impaired negative selection oft cells in Hodgkin's disease antigen CD30-deficient mice
22. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway
23. High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus
24. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells
25. CD30 prevents T-cell responses to non-lymphoid tissues
26. Functional effects of CD30 on a large granular lymphoma cell line, YT: Inhibitin of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation
27. Involvement of CD28 in MHC-umrestricted cytotoxicity mediated by a human natural killer leukemia cell line
28. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: Co-expressin of normal and aberrant receptors on Hut-102 cells
29. Transforming growth factor β1 inhibits Fas-L expression and subsequent activation-induced cell death in T cells via down regulation of c-myc
30. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of roiling T lymphocytes in peripheral lymph node high endothelial venules
31. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7
32. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
33. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase
34. NF-κB antiapoptosis: Induction of TRAF1 nd TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation
35. A novel domain in the CD30 cytoplasmic tail mediates NFκB activation